関連する実験動画
Updated: Jun 19, 2026

08:17
Murine Echocardiography of Left Atrium, Aorta, and Pulmonary Artery
Published on: February 20, 2017
身体の構成と左心室縮症の有病率
B Kuch1, H W Hense, B Gneiting
1Institute of Epidemiology and Social Medicine, Clinical Epidemiology Unit, University of Münster, Germany.
Circulation
|July 25, 2000
まとめ
左心室 (LV) 質量に対する無脂肪質量 (FFM) の正規化は,LV過剰症 (LVH) の性別特異的基準を排除する. この新しい方法は,特に肥満の個体において,LVHの罹患率の推定値を大幅に変更します.
科学分野:
- 心臓病学 心臓病学
- ボディコンポジション分析 分析
背景:
- 左心室 (LV) 質量正常化は,心臓の健康を評価するために重要である.
- 身長や身体表面積を用いた伝統的な方法には,性別特有の基準を含む限界があります.
- 脂肪のない質量 (FFM) は,LV質量のための潜在的な最適な体サイズ指数として浮上しています.
研究 の 目的:
- 左心室縮症 (LVH) の診断のための新しい無脂肪量 (FFM) ベースの基準を評価する.
- FFMインデックス化と伝統的な方法を用いて,LVHの罹患率を比較する.
- 異なる人口サブグループにおけるLVH検出に対するFFMインデックス化の影響を評価する.
主な方法:
- 1371人の成人 (25-74歳) にエコーカルディオグラフィとバイオ電気阻力分析が行われました.
- LVHの内部分割値は,LV質量/FFM,LV質量/高さ,LV質量/高さ,およびLV質量/体表面積を用いて確立されました.
- LVHの罹患率は,高血圧患者と肥満者を含む,異なるインデックス化方法と人口サブグループで比較されました.
主要な成果:
- LV質量/FFMは,性別中立のLVH基準 (4.1g/kg) を出した.
- LVHの罹患率の推定値は,インデックス化方法と人口サブグループによって著しく変化した.
- FFMインデックス化は,身長インデックス (OR2.5対5.5) と比較して,肥満の女性における LVHの明らかなリスクを大幅に低下させました.
結論:
- LV質量をFFMにインデックスすることで,性別特有の基準の必要性を排除することにより,LVHの評価を簡素化します.
- LVHの流行率は,FFMベースのインデックス化方法と伝統的なインデックス化方法の間で顕著に異なっています.
- FFMに基づくLVH基準の予後的意義を特定するために,特に肥満者などの特定の集団において,さらなる研究が必要である.
関連する概念動画
Pathophysiology of Heart Failure
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Imbalances in Cardiac Output
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Mitral Regurgitation I: Introduction
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Mitral Stenosis I: Introduction
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...

